Pre-order Enquiry
Request Free Sample
Global Migraine Therapeutics Market Research Report 2022
SKU ID : QYR-21415701 | Publishing Date : 03-Aug-2022 | No. of pages : 108
Detailed TOC of Global Migraine Therapeutics Market Research Report 2022
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Migraine Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Specific Anti-migraine Drugs
1.2.3 Acute Therapies
1.2.4 Preventative Therapies
1.2.5 Other
1.3 Market by Application
1.3.1 Global Migraine Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Household Use
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Migraine Therapeutics Market Perspective (2017-2028)
2.2 Migraine Therapeutics Growth Trends by Region
2.2.1 Migraine Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Migraine Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Migraine Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Migraine Therapeutics Market Dynamics
2.3.1 Migraine Therapeutics Industry Trends
2.3.2 Migraine Therapeutics Market Drivers
2.3.3 Migraine Therapeutics Market Challenges
2.3.4 Migraine Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Migraine Therapeutics Players by Revenue
3.1.1 Global Top Migraine Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Migraine Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Migraine Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Migraine Therapeutics Revenue
3.4 Global Migraine Therapeutics Market Concentration Ratio
3.4.1 Global Migraine Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Migraine Therapeutics Revenue in 2021
3.5 Migraine Therapeutics Key Players Head office and Area Served
3.6 Key Players Migraine Therapeutics Product Solution and Service
3.7 Date of Enter into Migraine Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Migraine Therapeutics Breakdown Data by Type
4.1 Global Migraine Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Migraine Therapeutics Forecasted Market Size by Type (2023-2028)
5 Migraine Therapeutics Breakdown Data by Application
5.1 Global Migraine Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Migraine Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Migraine Therapeutics Market Size (2017-2028)
6.2 North America Migraine Therapeutics Market Size by Country (2017-2022)
6.3 North America Migraine Therapeutics Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Migraine Therapeutics Market Size (2017-2028)
7.2 Europe Migraine Therapeutics Market Size by Country (2017-2022)
7.3 Europe Migraine Therapeutics Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Migraine Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Migraine Therapeutics Market Size by Country (2017-2022)
8.3 Asia-Pacific Migraine Therapeutics Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Migraine Therapeutics Market Size (2017-2028)
9.2 Latin America Migraine Therapeutics Market Size by Country (2017-2022)
9.3 Latin America Migraine Therapeutics Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Migraine Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Migraine Therapeutics Market Size by Country (2017-2022)
10.3 Middle East & Africa Migraine Therapeutics Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Detail
11.1.2 Allergan Business Overview
11.1.3 Allergan Migraine Therapeutics Introduction
11.1.4 Allergan Revenue in Migraine Therapeutics Business (2017-2022)
11.1.5 Allergan Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Migraine Therapeutics Introduction
11.2.4 Merck Revenue in Migraine Therapeutics Business (2017-2022)
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Migraine Therapeutics Introduction
11.3.4 Pfizer Revenue in Migraine Therapeutics Business (2017-2022)
11.3.5 Pfizer Recent Development
11.4 Teva
11.4.1 Teva Company Detail
11.4.2 Teva Business Overview
11.4.3 Teva Migraine Therapeutics Introduction
11.4.4 Teva Revenue in Migraine Therapeutics Business (2017-2022)
11.4.5 Teva Recent Development
11.5 Amgen
11.5.1 Amgen Company Detail
11.5.2 Amgen Business Overview
11.5.3 Amgen Migraine Therapeutics Introduction
11.5.4 Amgen Revenue in Migraine Therapeutics Business (2017-2022)
11.5.5 Amgen Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Migraine Therapeutics Introduction
11.6.4 Johnson & Johnson Revenue in Migraine Therapeutics Business (2017-2022)
11.6.5 Johnson & Johnson Recent Development
11.7 Endo International
11.7.1 Endo International Company Detail
11.7.2 Endo International Business Overview
11.7.3 Endo International Migraine Therapeutics Introduction
11.7.4 Endo International Revenue in Migraine Therapeutics Business (2017-2022)
11.7.5 Endo International Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Detail
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Migraine Therapeutics Introduction
11.8.4 GlaxoSmithKline Revenue in Migraine Therapeutics Business (2017-2022)
11.8.5 GlaxoSmithKline Recent Development
11.9 Impax
11.9.1 Impax Company Detail
11.9.2 Impax Business Overview
11.9.3 Impax Migraine Therapeutics Introduction
11.9.4 Impax Revenue in Migraine Therapeutics Business (2017-2022)
11.9.5 Impax Recent Development
11.10 Abbott
11.10.1 Abbott Company Detail
11.10.2 Abbott Business Overview
11.10.3 Abbott Migraine Therapeutics Introduction
11.10.4 Abbott Revenue in Migraine Therapeutics Business (2017-2022)
11.10.5 Abbott Recent Development
11.11 Bayer
11.11.1 Bayer Company Detail
11.11.2 Bayer Business Overview
11.11.3 Bayer Migraine Therapeutics Introduction
11.11.4 Bayer Revenue in Migraine Therapeutics Business (2017-2022)
11.11.5 Bayer Recent Development
11.12 Eli Lilly
11.12.1 Eli Lilly Company Detail
11.12.2 Eli Lilly Business Overview
11.12.3 Eli Lilly Migraine Therapeutics Introduction
11.12.4 Eli Lilly Revenue in Migraine Therapeutics Business (2017-2022)
11.12.5 Eli Lilly Recent Development
11.13 Novartis International
11.13.1 Novartis International Company Detail
11.13.2 Novartis International Business Overview
11.13.3 Novartis International Migraine Therapeutics Introduction
11.13.4 Novartis International Revenue in Migraine Therapeutics Business (2017-2022)
11.13.5 Novartis International Recent Development
11.14 Ethypharm
11.14.1 Ethypharm Company Detail
11.14.2 Ethypharm Business Overview
11.14.3 Ethypharm Migraine Therapeutics Introduction
11.14.4 Ethypharm Revenue in Migraine Therapeutics Business (2017-2022)
11.14.5 Ethypharm Recent Development
11.15 Kowa Pharmaceuticals America
11.15.1 Kowa Pharmaceuticals America Company Detail
11.15.2 Kowa Pharmaceuticals America Business Overview
11.15.3 Kowa Pharmaceuticals America Migraine Therapeutics Introduction
11.15.4 Kowa Pharmaceuticals America Revenue in Migraine Therapeutics Business (2017-2022)
11.15.5 Kowa Pharmaceuticals America Recent Development
11.16 Winston Pharmaceuticals
11.16.1 Winston Pharmaceuticals Company Detail
11.16.2 Winston Pharmaceuticals Business Overview
11.16.3 Winston Pharmaceuticals Migraine Therapeutics Introduction
11.16.4 Winston Pharmaceuticals Revenue in Migraine Therapeutics Business (2017-2022)
11.16.5 Winston Pharmaceuticals Recent Development
11.17 AstraZeneca
11.17.1 AstraZeneca Company Detail
11.17.2 AstraZeneca Business Overview
11.17.3 AstraZeneca Migraine Therapeutics Introduction
11.17.4 AstraZeneca Revenue in Migraine Therapeutics Business (2017-2022)
11.17.5 AstraZeneca Recent Development
11.18 Amirall
11.18.1 Amirall Company Detail
11.18.2 Amirall Business Overview
11.18.3 Amirall Migraine Therapeutics Introduction
11.18.4 Amirall Revenue in Migraine Therapeutics Business (2017-2022)
11.18.5 Amirall Recent Development
11.19 OptiNose
11.19.1 OptiNose Company Detail
11.19.2 OptiNose Business Overview
11.19.3 OptiNose Migraine Therapeutics Introduction
11.19.4 OptiNose Revenue in Migraine Therapeutics Business (2017-2022)
11.19.5 OptiNose Recent Development
11.20 Revance Therapeutics
11.20.1 Revance Therapeutics Company Detail
11.20.2 Revance Therapeutics Business Overview
11.20.3 Revance Therapeutics Migraine Therapeutics Introduction
11.20.4 Revance Therapeutics Revenue in Migraine Therapeutics Business (2017-2022)
11.20.5 Revance Therapeutics Recent Development
11.21 RedHill Biopharma
11.21.1 RedHill Biopharma Company Detail
11.21.2 RedHill Biopharma Business Overview
11.21.3 RedHill Biopharma Migraine Therapeutics Introduction
11.21.4 RedHill Biopharma Revenue in Migraine Therapeutics Business (2017-2022)
11.21.5 RedHill Biopharma Recent Development
11.22 Bausch Health
11.22.1 Bausch Health Company Detail
11.22.2 Bausch Health Business Overview
11.22.3 Bausch Health Migraine Therapeutics Introduction
11.22.4 Bausch Health Revenue in Migraine Therapeutics Business (2017-2022)
11.22.5 Bausch Health Recent Development
11.23 NeurAxon
11.23.1 NeurAxon Company Detail
11.23.2 NeurAxon Business Overview
11.23.3 NeurAxon Migraine Therapeutics Introduction
11.23.4 NeurAxon Revenue in Migraine Therapeutics Business (2017-2022)
11.23.5 NeurAxon Recent Development
11.24 Biohaven Pharma
11.24.1 Biohaven Pharma Company Detail
11.24.2 Biohaven Pharma Business Overview
11.24.3 Biohaven Pharma Migraine Therapeutics Introduction
11.24.4 Biohaven Pharma Revenue in Migraine Therapeutics Business (2017-2022)
11.24.5 Biohaven Pharma Recent Development
11.25 Eisai
11.25.1 Eisai Company Detail
11.25.2 Eisai Business Overview
11.25.3 Eisai Migraine Therapeutics Introduction
11.25.4 Eisai Revenue in Migraine Therapeutics Business (2017-2022)
11.25.5 Eisai Recent Development
11.26 Valeant Pharma
11.26.1 Valeant Pharma Company Detail
11.26.2 Valeant Pharma Business Overview
11.26.3 Valeant Pharma Migraine Therapeutics Introduction
11.26.4 Valeant Pharma Revenue in Migraine Therapeutics Business (2017-2022)
11.26.5 Valeant Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Migraine Therapeutics Market Research Report 2022
List of TablesTable 1. Global Migraine Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Specific Anti-migraine Drugs
Table 3. Key Players of Acute Therapies
Table 4. Key Players of Preventative Therapies
Table 5. Key Players of Other
Table 6. Global Migraine Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Migraine Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Migraine Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Migraine Therapeutics Market Share by Region (2017-2022)
Table 10. Global Migraine Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Migraine Therapeutics Market Share by Region (2023-2028)
Table 12. Migraine Therapeutics Market Trends
Table 13. Migraine Therapeutics Market Drivers
Table 14. Migraine Therapeutics Market Challenges
Table 15. Migraine Therapeutics Market Restraints
Table 16. Global Migraine Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Migraine Therapeutics Market Share by Players (2017-2022)
Table 18. Global Top Migraine Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Therapeutics as of 2021)
Table 19. Ranking of Global Top Migraine Therapeutics Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Migraine Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Migraine Therapeutics Product Solution and Service
Table 23. Date of Enter into Migraine Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Migraine Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Migraine Therapeutics Revenue Market Share by Type (2017-2022)
Table 27. Global Migraine Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Migraine Therapeutics Revenue Market Share by Type (2023-2028)
Table 29. Global Migraine Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Migraine Therapeutics Revenue Market Share by Application (2017-2022)
Table 31. Global Migraine Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Migraine Therapeutics Revenue Market Share by Application (2023-2028)
Table 33. North America Migraine Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Migraine Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Migraine Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Migraine Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Migraine Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Migraine Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Migraine Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Migraine Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Migraine Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Migraine Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 43. Allergan Company Detail
Table 44. Allergan Business Overview
Table 45. Allergan Migraine Therapeutics Product
Table 46. Allergan Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 47. Allergan Recent Development
Table 48. Merck Company Detail
Table 49. Merck Business Overview
Table 50. Merck Migraine Therapeutics Product
Table 51. Merck Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 52. Merck Recent Development
Table 53. Pfizer Company Detail
Table 54. Pfizer Business Overview
Table 55. Pfizer Migraine Therapeutics Product
Table 56. Pfizer Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 57. Pfizer Recent Development
Table 58. Teva Company Detail
Table 59. Teva Business Overview
Table 60. Teva Migraine Therapeutics Product
Table 61. Teva Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 62. Teva Recent Development
Table 63. Amgen Company Detail
Table 64. Amgen Business Overview
Table 65. Amgen Migraine Therapeutics Product
Table 66. Amgen Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 67. Amgen Recent Development
Table 68. Johnson & Johnson Company Detail
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Migraine Therapeutics Product
Table 71. Johnson & Johnson Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 72. Johnson & Johnson Recent Development
Table 73. Endo International Company Detail
Table 74. Endo International Business Overview
Table 75. Endo International Migraine Therapeutics Product
Table 76. Endo International Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 77. Endo International Recent Development
Table 78. GlaxoSmithKline Company Detail
Table 79. GlaxoSmithKline Business Overview
Table 80. GlaxoSmithKline Migraine Therapeutics Product
Table 81. GlaxoSmithKline Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 82. GlaxoSmithKline Recent Development
Table 83. Impax Company Detail
Table 84. Impax Business Overview
Table 85. Impax Migraine Therapeutics Product
Table 86. Impax Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 87. Impax Recent Development
Table 88. Abbott Company Detail
Table 89. Abbott Business Overview
Table 90. Abbott Migraine Therapeutics Product
Table 91. Abbott Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 92. Abbott Recent Development
Table 93. Bayer Company Detail
Table 94. Bayer Business Overview
Table 95. Bayer Migraine TherapeuticsProduct
Table 96. Bayer Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 97. Bayer Recent Development
Table 98. Eli Lilly Company Detail
Table 99. Eli Lilly Business Overview
Table 100. Eli Lilly Migraine TherapeuticsProduct
Table 101. Eli Lilly Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 102. Eli Lilly Recent Development
Table 103. Novartis International Company Detail
Table 104. Novartis International Business Overview
Table 105. Novartis International Migraine TherapeuticsProduct
Table 106. Novartis International Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 107. Novartis International Recent Development
Table 108. Ethypharm Company Detail
Table 109. Ethypharm Business Overview
Table 110. Ethypharm Migraine TherapeuticsProduct
Table 111. Ethypharm Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 112. Ethypharm Recent Development
Table 113. Kowa Pharmaceuticals America Company Detail
Table 114. Kowa Pharmaceuticals America Business Overview
Table 115. Kowa Pharmaceuticals America Migraine TherapeuticsProduct
Table 116. Kowa Pharmaceuticals America Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 117. Kowa Pharmaceuticals America Recent Development
Table 118. Winston Pharmaceuticals Company Detail
Table 119. Winston Pharmaceuticals Business Overview
Table 120. Winston Pharmaceuticals Migraine TherapeuticsProduct
Table 121. Winston Pharmaceuticals Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 122. Winston Pharmaceuticals Recent Development
Table 123. AstraZeneca Company Detail
Table 124. AstraZeneca Business Overview
Table 125. AstraZeneca Migraine TherapeuticsProduct
Table 126. AstraZeneca Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 127. AstraZeneca Recent Development
Table 128. Amirall Company Detail
Table 129. Amirall Business Overview
Table 130. Amirall Migraine TherapeuticsProduct
Table 131. Amirall Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 132. Amirall Recent Development
Table 133. OptiNose Company Detail
Table 134. OptiNose Business Overview
Table 135. OptiNose Migraine TherapeuticsProduct
Table 136. OptiNose Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 137. OptiNose Recent Development
Table 138. Revance Therapeutics Company Detail
Table 139. Revance Therapeutics Business Overview
Table 140. Revance Therapeutics Migraine TherapeuticsProduct
Table 141. Revance Therapeutics Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 142. Revance Therapeutics Recent Development
Table 143. RedHill Biopharma Company Detail
Table 144. RedHill Biopharma Business Overview
Table 145. RedHill Biopharma Migraine TherapeuticsProduct
Table 146. RedHill Biopharma Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 147. RedHill Biopharma Recent Development
Table 148. Bausch Health Company Detail
Table 149. Bausch Health Business Overview
Table 150. Bausch Health Migraine TherapeuticsProduct
Table 151. Bausch Health Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 152. Bausch Health Recent Development
Table 153. NeurAxon Company Detail
Table 154. NeurAxon Business Overview
Table 155. NeurAxon Migraine TherapeuticsProduct
Table 156. NeurAxon Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 157. NeurAxon Recent Development
Table 158. Biohaven Pharma Company Detail
Table 159. Biohaven Pharma Business Overview
Table 160. Biohaven Pharma Migraine TherapeuticsProduct
Table 161. Biohaven Pharma Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 162. Biohaven Pharma Recent Development
Table 163. Eisai Company Detail
Table 164. Eisai Business Overview
Table 165. Eisai Migraine TherapeuticsProduct
Table 166. Eisai Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 167. Eisai Recent Development
Table 168. Valeant Pharma Company Detail
Table 169. Valeant Pharma Business Overview
Table 170. Valeant Pharma Migraine TherapeuticsProduct
Table 171. Valeant Pharma Revenue in Migraine Therapeutics Business (2017-2022) & (US$ Million)
Table 172. Valeant Pharma Recent Development
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Migraine Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Specific Anti-migraine Drugs Features
Figure 3. Acute Therapies Features
Figure 4. Preventative Therapies Features
Figure 5. Other Features
Figure 6. Global Migraine Therapeutics Market Share by Application in 2021 & 2028
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Household Use Case Studies
Figure 10. Others Case Studies
Figure 11. Migraine Therapeutics Report Years Considered
Figure 12. Global Migraine Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Migraine Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Migraine Therapeutics Market Share by Region: 2021 VS 2028
Figure 15. Global Migraine Therapeutics Market Share by Players in 2021
Figure 16. Global Top Migraine Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Therapeutics as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Migraine Therapeutics Revenue in 2021
Figure 18. North America Migraine Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Migraine Therapeutics Market Share by Country (2017-2028)
Figure 20. United States Migraine Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Migraine Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Migraine Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Migraine Therapeutics Market Share by Country (2017-2028)
Figure 24. Germany Migraine Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Migraine Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Migraine Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Migraine Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Migraine Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Migraine Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Migraine Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Migraine Therapeutics Market Share by Region (2017-2028)
Figure 32. China Migraine Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Migraine Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Migraine Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Migraine Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Migraine Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Migraine Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Migraine Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Migraine Therapeutics Market Share by Country (2017-2028)
Figure 40. Mexico Migraine Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Migraine Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Migraine Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Migraine Therapeutics Market Share by Country (2017-2028)
Figure 44. Turkey Migraine Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Migraine Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Allergan Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 47. Merck Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 48. Pfizer Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 49. Teva Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 50. Amgen Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 51. Johnson & Johnson Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 52. Endo International Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 54. Impax Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 55. Abbott Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 56. Bayer Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 57. Eli Lilly Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 58. Novartis International Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 59. Ethypharm Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 60. Kowa Pharmaceuticals America Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 61. Winston Pharmaceuticals Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 62. AstraZeneca Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 63. Amirall Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 64. OptiNose Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 65. Revance Therapeutics Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 66. RedHill Biopharma Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 67. Bausch Health Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 68. NeurAxon Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 69. Biohaven Pharma Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 70. Eisai Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 71. Valeant Pharma Revenue Growth Rate in Migraine Therapeutics Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Keyplayers in Global Migraine Therapeutics Market Research Report 2022
AllerganMerck
Pfizer
Teva
Amgen
Johnson & Johnson
Endo International
GlaxoSmithKline
Impax
Abbott
Bayer
Eli Lilly
Novartis International
Ethypharm
Kowa Pharmaceuticals America
Winston Pharmaceuticals
AstraZeneca
Amirall
OptiNose
Revance Therapeutics
RedHill Biopharma
Bausch Health
NeurAxon
Biohaven Pharma
Eisai
Valeant Pharma
Request Sample
Request Discount
